Latest Peplin news



news 

01-Feb-10

LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition read more

21-Dec-09

Positive Results for LEO Pharma's Phase III Actinic Keratosis Trials on the Face and Scalp read more

12-Nov-09

Letter to our CDI Holders read more


Contact Us


Clinical trial information

Please refer to www.clinicaltrials.gov for trial information

Corporate information

AUSTRALIA

Street Address
Level 3, Tower One
25 Montpelier Road
Bowen Hills, Queensland 4006

Postal Address
PO Box 3325
Newstead LPO
QLD, 4006, Australia

Telephone: +61-7-3250 1200
Facsimile: +61-7-3250 1299
Email: info@peplin.com
Website: www.peplin.com